The trials began in Abu Dhabi on 16th July and are being managed by G4 Healthcare in partnership with the Department of Health – Abu Dhabi, the UAE Ministry of Health and Prevention (MOHAP) and Abu Dhabi Health Services Company (SEHA). They are being conducted following the international guidelines stipulated by the World Health Organization (WHO).